Healthcare Antitrust
Overview
Antitrust has long been a particular strength of our healthcare litigation group. We have successfully represented providers in many of the leading healthcare antitrust cases, including matters brought by the Federal Trade Commission, the U.S. Department of Justice, state attorneys general and private litigants. Our lawyers combine a strong background in the complexities of pharmaceutical and healthcare financing and delivery with extensive experience in the substantive laws governing mergers, price-fixing, monopolization, tying, price discrimination and other aspects of antitrust law. Several of our partners hold leadership positions in professional organizations dealing with antitrust and healthcare issues. Our lawyers include a former Commissioner at the Federal Trade Commission and a former Deputy Assistant Attorney General for Merger Enforcement at the Antitrust Division of the U.S. Department of Justice.
News & Insights
U.S. DOJ Announces Renewal of FCA Working GroupJuly 7, 2025DOJ Antitrust Division and HHS Inspector General Sign Memorandum of Understanding to Strengthen CoordinationDecember 20, 2022EU Court of Justice Rules on Lundbeck Patent Settlement AgreementsMay 2021FTC Targets M&A Agreements in Continued Campaign Against Noncompete and No-Poach ClausesFebruary 21, 2020
Healthcare Update
Global Life Sciences Update
Competition Policy International
Antitrust Update
U.S. DOJ Announces Renewal of FCA Working GroupJuly 7, 2025DOJ Antitrust Division and HHS Inspector General Sign Memorandum of Understanding to Strengthen CoordinationDecember 20, 2022FTC Targets M&A Agreements in Continued Campaign Against Noncompete and No-Poach ClausesFebruary 21, 2020
Healthcare Update
Global Life Sciences Update
Antitrust Update
Capabilities
All Professionals
sort











